Dubuque Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Dubuque Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$662K	Buy	11,406 +795	+7%	+$48.7K	0.09%	111
2023 Q2	$679K	Sell	10,611 -76	-0.7%	-$5.1K	0.09%	107
2023 Q1	$741K	Sell	10,687 -1,403	-12%	-$99K	0.1%	99
2022 Q4	$870K	Sell	12,090 -160	-1%	-$12.1K	0.11%	98
2022 Q3	$871K	Sell	12,250 -425	-3%	-$30.8K	0.12%	94
2022 Q2	$976K	Sell	12,675 -38	-0.3%	-$2.89K	0.13%	92
2022 Q1	$928K	Sell	12,713 -68	-0.5%	-$4.57K	0.1%	100
2021 Q4	$797K	Sell	12,781 -85	-0.7%	-$4.99K	0.08%	118
2021 Q3	$761K	Sell	12,866 -169	-1%	-$11.1K	0.09%	120
2021 Q2	$871K	Sell	13,035 -1,845	-12%	-$120K	0.1%	119
2021 Q1	$939K	Sell	14,880 -112	-0.7%	-$6.97K	0.11%	110
2020 Q4	$930K	Buy	14,992 +3,118	+26%	+$192K	0.11%	106
2020 Q3	$716K	Sell	11,874 -165	-1%	-$9.93K	0.11%	114
2020 Q2	$708K	Sell	12,039 -106	-0.9%	-$6.34K	0.11%	114
2020 Q1	$677K	Buy	12,145 +2,135	+21%	+$130K	0.13%	113
2019 Q4	$642K	Buy	10,010 +799	+9%	+$45.8K	0.1%	113
2019 Q3	$467K	Sell	9,211 -76	-0.8%	-$3.57K	0.08%	117
2019 Q2	$422K	Buy	9,287 +105	+1%	+$4.89K	0.07%	122
2019 Q1	$438K	Buy	9,182 +76	+0.8%	+$3.79K	0.07%	112
2018 Q4	$473K	Sell	9,106 -134	-1%	-$7.2K	0.09%	103
2018 Q3	$573K	Sell	9,240 -265	-3%	-$15.7K	0.09%	94
2018 Q2	$526K	Hold	9,505	–	–	0.09%	94
2018 Q1	$601K	Sell	9,505 -114	-1%	-$7.33K	0.1%	96
2017 Q4	$589K	Hold	9,619	–	–	0.09%	104
2017 Q3	$613K	Sell	9,619 -1,047	-10%	-$61.1K	0.1%	102
2017 Q2	$594K	Sell	10,666 -6,623	-38%	-$360K	0.13%	99
2017 Q1	$940K	Buy	17,289 +1,307	+8%	+$71.7K	0.21%	82
2016 Q4	$934K	Buy	15,982 +1,815	+13%	+$99.2K	0.17%	84
2016 Q3	$764K	Buy	14,167 +400	+3%	+$25.7K	0.14%	89
2016 Q2	$1.01M	Sell	13,767 -857	-6%	-$60.6K	0.2%	91
2016 Q1	$934K	Sell	14,624 -500	-3%	-$31.5K	0.18%	100
2015 Q4	$1.04M	Buy	15,124 +150	+1%	+$9.91K	0.22%	100
2015 Q3	$886K	Buy	14,974 +1,550	+12%	+$98.3K	0.19%	111
2015 Q2	$893K	Buy	13,424 +18	+0.1%	+$1.19K	0.17%	113
2015 Q1	$865K	Buy	13,406 +406	+3%	+$25.4K	0.13%	113
2014 Q4	$767K	Hold	13,000	–	–	0.12%	79
2014 Q3	$665K	Hold	13,000	–	–	0.11%	81
2014 Q2	$631K	Hold	13,000	–	–	0.1%	89
2014 Q1	$675K	Hold	13,000	–	–	0.12%	83
2013 Q4	$691K	Hold	13,000	–	–	0.12%	82
2013 Q3	$602K	Hold	13,000	–	–	0.11%	84
2013 Q2	$581K	Buy	+13,000	New	+$564K	0.11%	76

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dubuque Bank & Trust's BMY Position: Q3 2023 in Review

Dubuque Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 7.5% in Q3 2023, buying an estimated $48.7K and bringing the position to 11,406 shares worth $662K. The position accounts for 0.09% of the portfolio, ranked #111.

Dubuque Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 42 quarters since. The position peaked at $1.04M in Q4 2015. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Dubuque Bank & Trust held 11,406 shares of Bristol-Myers Squibb worth $662K as of Q3 2023.
Dubuque Bank & Trust bought 795 Bristol-Myers Squibb shares in Q3 2023, an estimated $48.7K.
Bristol-Myers Squibb made up 0.09% of Dubuque Bank & Trust's portfolio in Q3 2023, its #111 holding.
Dubuque Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 42 quarters since.
Dubuque Bank & Trust's Bristol-Myers Squibb position peaked at $1.04M in Q4 2015.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Dubuque Bank & Trust's 13F filing for Q3 2023, filed 27 Oct 2023.